Coral Gables, Florida Clinical Trials

A listing of Coral Gables, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 65 clinical trials
High-Speed Yoga and Executive Function

The purpose of this research study is to establish if a novel high-speed yoga program which incorporates visual cues can make a positive change in the participant's ability to make decisions and move as measured by several cognitive, balance and functional tests. It has been shown that yoga can improve …

parkinson's disease
neuromuscular diseases
cancer
cardiovascular disease
stroke
Max Orovitz Laboratories
 (0.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Baumann Cosmetic & Research Institute, Inc
 (8.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)

The purpose of this study is to assess the hematologic effects of IMG-7289 therapy in ET and PV patients who require platelet, White Blood Cell (WBC) or Red Blood Cell (RBC) control, and have failed at least one standard therapy.

platelet count
fibrosis
myelofibrosis
neutrophil count
myeloproliferative disorder
University of Miami
 (6.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of LY3372993 in Participants With Alzheimer's Disease (AD)

The main purpose of this study is to evaluate the safety and tolerability of LY3372993 in participants with AD. The study will also investigate how much LY3372993 gets into the bloodstream and will test the effects of LY3372993. Participation could last up to about 54 weeks and may include up …

mental state examination
alzheimer's disease
mild cognitive impairment
mini-mental state examination
dementia
IMIC, Inc.
 (8.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to three dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a …

Driven Research- Site Number : 8400135
 (2.4 away) Contact site
  • 0 views
  • 29 Nov, 2025
  • +30 other locations
None

Sylvester Comprehensive Cancer Center & Jackson Memorial Hospital
 (6.0 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +1 other locations
PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients

An Open-label study for patients who completed the previous studies, PTI-125-02 or PTI-125-03. Additional new patients will be included for a total of 100 patients enrolled for this study.

alzheimer's disease
amyloidosis
memantine
donepezil
dementia
Optimus U
 (4.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +8 other locations
A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of pulsed inhaled iNO compared to placebo in subjects with COVID-19.

SARS
pneumonia
x-rays
acute respiratory syndrome (sars)
covid-19
University of Miami Health System
 (6.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +13 other locations
A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects

This is a randomized, single-blind, placebo-controlled, once daily (QD) dose study of CRV431 in presumed NASH F2/F3 subjects.

vcte
fibrosis
hepatic fibrosis
fibroscan
fatty liver
La Salud Research, Inc.
 (3.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
Study to Evaluate Safety Tolerability Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes

This study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of JTT-662 administered once daily for 28 days in subjects with Type 2 diabetes mellitus (T2DM) who are receiving metformin monotherapy

fasting
body mass index
metformin
plasma glucose
Qps-Mra, Llc
 (2.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location